Imuran: Immunosuppressive Therapy for Autoimmune Disorders
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.00 | $60.27 (0%) | 🛒 Add to cart |
| 90 | $0.94 | $90.41 $84.38 (7%) | 🛒 Add to cart |
| 120 | $0.90 | $120.54 $108.49 (10%) | 🛒 Add to cart |
| 180 | $0.88 | $180.82 $157.71 (13%) | 🛒 Add to cart |
| 270 | $0.85 | $271.22 $230.04 (15%) | 🛒 Add to cart |
| 360 | $0.84
Best per pill | $361.63 $303.37 (16%) | 🛒 Add to cart |
Synonyms | |||
Imuran (azathioprine) is an immunosuppressive medication used to prevent organ rejection in transplant recipients and to manage a range of autoimmune conditions. By selectively inhibiting purine synthesis, it modulates overactive immune responses, reducing inflammation and disease progression. This oral formulation offers a well-established option for long-term immunomodulation under specialist supervision.
Features
- Active ingredient: Azathioprine
- Available in 25 mg, 50 mg, and 75 mg scored tablets
- Oral administration, typically once or twice daily
- Generic versions available
- Requires regular blood monitoring during therapy
- Pregnancy Category D: positive evidence of human fetal risk
Benefits
- Reduces the risk of organ transplant rejection
- Controls disease activity in autoimmune disorders like rheumatoid arthritis and lupus
- May enable reduction of corticosteroid doses
- Can induce long-term remission in inflammatory bowel disease
- Well-established safety profile with decades of clinical use
- Oral formulation supports outpatient management
Common use
Imuran is primarily indicated for prevention of kidney transplant rejection, typically in combination with other immunosuppressants. It is also used for autoimmune conditions including rheumatoid arthritis, systemic lupus erythematosus, autoimmune hepatitis, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), and certain dermatological conditions like pemphigus vulgaris. The medication is generally reserved for cases where corticosteroids alone provide insufficient control or where steroid-sparing effects are desired.
Dosage and direction
Dosage must be individualized based on patient weight, indication, and tolerance. For transplant patients: initial dose is usually 3-5 mg/kg daily, then maintenance dose of 1-3 mg/kg daily. For autoimmune diseases: starting dose is typically 1 mg/kg daily, which may be increased gradually to 2.5 mg/kg daily if needed and tolerated. Tablets should be taken with food to minimize gastrointestinal upset. Regular complete blood count monitoring is essential, particularly during the first 8 weeks of therapy and after dosage changes.
Precautions
Patients require regular monitoring of complete blood counts, liver function tests, and renal function. Increased susceptibility to infections may occur. Avoid live vaccines during treatment. Use sun protection due to increased photosensitivity risk. Patients should be advised to report any signs of infection, unusual bleeding, or jaundice promptly. Careful dosage adjustment is necessary in patients with impaired renal function or those taking allopurinol.
Contraindications
Hypersensitivity to azathioprine or any component of the formulation. Patients with rheumatoid arthritis who have been treated with alkylating agents (cyclophosphamide, chlorambucil, melphalan) may have an increased risk of neoplasia. Not recommended during pregnancy unless potential benefits justify potential risks to the fetus. Should not be used in patients with absent thiopurine methyltransferase (TPMT) activity.
Possible side effect
Common: nausea, vomiting, diarrhea, leukopenia, thrombocytopenia. Serious: severe bone marrow suppression, hepatotoxicity, increased susceptibility to infections, pancreatitis, increased risk of malignancies (particularly skin cancer and lymphoma), hypersensitivity reactions. Gastrointestinal symptoms often diminish with continued therapy or dose reduction. Regular monitoring helps detect hematological abnormalities early.
Drug interaction
Allopurinol inhibits xanthine oxidase, dramatically increasing azathioprine toxicity - dose reduction to 25-33% of usual dose is required. Warfarin effect may be reduced. May potentiate effects of other bone marrow suppressants. ACE inhibitors may increase risk of anemia. Live vaccines should be avoided. Aminosalicylate derivatives (e.g., mesalazine) may increase risk of myelosuppression.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed one. If vomiting occurs shortly after taking the medication, contact your healthcare provider for advice regarding repeating the dose. Maintain regular dosing schedule to ensure consistent immunosuppression.
Overdose
Symptoms may include nausea, vomiting, diarrhea, and hematological toxicity including leukopenia, thrombocytopenia, and bleeding. In severe cases, bone marrow suppression and infection may occur. Treatment is supportive with gastric lavage if recent ingestion, followed by intensive supportive care including transfusion of blood products and infection management. Hemodialysis is not effective due to high protein binding.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place protected from light. Keep in original container with lid tightly closed. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Do not transfer tablets to other containers as moisture protection may be compromised.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Treatment decisions should be made in consultation with a qualified healthcare provider familiar with the patient’s specific medical history. Dosage and administration may vary based on individual patient factors and treatment response.
Reviews
Clinical studies demonstrate Imuran’s efficacy in maintaining transplant graft survival and controlling autoimmune disease activity. Many patients report improved quality of life with reduced disease flares and corticosteroid requirements. However, the requirement for regular monitoring and potential side effects are frequently noted considerations. Specialist physicians generally regard it as a valuable option in the immunosuppressive arsenal when used with appropriate monitoring and patient selection.